EllieMD's GLP-1 plus NAD oral drops combine two biologically active compounds in one formulation. Here is why, what each contributes, and who the combination is designed for.

Among EllieMD's weight loss program options are formulations that combine GLP-1 medication with NAD oral drops. If you have noticed these on the program page and wondered what the rationale is for combining them, this article explains what each component contributes and why the pairing makes clinical sense for certain patients.

What Each Component Does Independently

GLP-1 medication in oral drop form provides the core appetite-suppressing and metabolic effects of GLP-1 receptor agonism. As covered in our article on oral drops versus injectables, the sublingual delivery route offers a needle-free alternative to injectable semaglutide with bioavailability that, while lower than injectable, produces meaningful clinical effects for appropriate patients.

NAD (nicotinamide adenine dinucleotide) precursors in oral formulations support cellular energy metabolism through the pathways covered extensively in our NAD+ articles. The oral drop delivery allows sublingual absorption that may offer better bioavailability than standard oral tablet formulations by allowing some absorption through the oral mucosa before the compound reaches the gut.

Why Combining Them Makes Sense for Some Patients

The pairing reflects a specific patient profile: someone who wants the metabolic and appetite benefits of GLP-1 therapy, prefers a needle-free delivery format, and also wants NAD+ support for the cellular energy and longevity dimensions of their health goals.

The two compounds work through entirely different mechanisms and do not interfere with each other. GLP-1 works at the receptor level in the gut and brain. NAD+ precursors work at the mitochondrial level in cells throughout the body. They address different biological systems in parallel.

For patients who are interested in both weight management and the broader longevity benefits of NAD+ support, the combined formulation offers a practical delivery option that combines two daily requirements into one. There is a genuine convenience advantage for patients who would otherwise need to manage two separate supplementation routines.

The patient who benefits most from this combination is typically someone for whom needle avoidance is important, who has some motivation for longevity or cognitive energy optimization alongside weight loss, and whose physician has assessed that both components are clinically appropriate.

Who This Formulation Is Not For

Patients who want maximum weight loss effect and have no needle aversion are likely better served by the injectable formulations, which offer higher GLP-1 bioavailability than oral drops.

Patients whose primary NAD+ support goal is brain-targeted delivery might do better with the NAD+ nasal spray formulation, which the nasal-to-brain pathway may serve more directly.

Patients who need the L-carnitine addition to support fat oxidation specifically, particularly those prioritizing lean mass preservation during significant weight loss, may be better served by the GLP-1 plus L-carnitine injectable.

These are distinctions your physician navigates during the consultation, not decisions you need to make based on reading product descriptions alone.


Individual results may vary. All prescriptions require approval by a licensed medical provider. Compounded medications are not FDA-approved. EllieMD facilitates access to independent healthcare providers and pharmacies and does not provide medical care or dispense medications.